Gastrointestinal Cancer News

The development of more effective treatments — including personalized therapies — have dramatically improved outcomes for children and adolescents with cancer, according to American Association for Cancer Research’s Cancer Progress Report.

The addition of retifanlimab to standard first-line chemotherapy improved outcomes for certain patients with advanced squamous cell carcinoma of the anal canal, according to randomized phase 3 study results presented at ESMO Congress.

The addition of lenvatinib and pembrolizumab to transarterial chemoembolization extended PFS for patients with intermediate-stage hepatocellular carcinoma, according to randomized phase 3 study results.

The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection.

The combination of a ketogenic diet and an experimental MNK inhibitor may be able to shrink pancreatic cancer tumors, according to preliminary study findings.

Modified FOLFIRINOX induction chemotherapy prior to standard chemoradiation, surgery and adjuvant chemotherapy improved outcomes for patients with locally advanced rectal cancer, according to a long-term analysis of a randomized phase 3 trial.

Women with hepatocellular carcinoma were less likely to receive a liver transplant and more likely to die or be removed from the waitlist vs. men, underscoring the need for changes to allocation policies, according to researchers.

Although training primary care providers in shared decision-making did not significantly improve colorectal cancer concordance or screening rates in older adults, at least 5 minutes of discussion with a PCP may benefit some, data showed.

Alessio Pigazzi, MD, PhD, has been appointed executive medical director of colorectal surgery at City of Hope Orange County.